William Johnson
Pediatric Allergy/Immunology Saint Louis, MO Medical Doctor
NPI 1669476495 CMS profile 302077
1 Childrens Pl, Saint Louis, MO 63110
General payments
$6,687
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$741,690
Through program year 2024, William Johnson of Saint Louis, MO is reported in the CMS Open Payments database as having received $6,687 across 376 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $741,690 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 70th percentile of Pediatric Allergy/Immunology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
6 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $175 | 1 | |
| 2023 | General | $1,164 | 57 | |
| 2022 | General | $2,375 | 138 | |
| 2021 | General | $1,664 | 103 | |
| 2020 | General | $767 | 43 | |
| 2019 | General | $542 | 34 |
Beside peers
- William Johnson
- Pediatric Allergy/Immunology median
- Middle half of Pediatric Allergy/Immunology
- National median
In program year 2025, general payments to William Johnson were reported at $0. Among 289 Pediatric Allergy/Immunology profiles paid that year, the median was $361 and the middle half received between $125 and $2,493.
Show as a table
| Year | William Johnson | Pediatric Allergy/Immunology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $542 | $325 | $92–$1,399 | $163 |
| 2020 | $767 | $144 | $66–$2,490 | $114 |
| 2021 | $1,664 | $357 | $95–$2,633 | $132 |
| 2022 | $2,375 | $385 | $125–$2,259 | $149 |
| 2023 | $1,164 | $470 | $121–$2,946 | $160 |
| 2024 | $175 | $317 | $125–$2,583 | $164 |
| 2025 | $0 | $361 | $125–$2,493 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 11 drugsPart D claims
217
Drug cost
$55,713
Branded share of claims
58.1%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | Brand | 41 | $33,946 | |
| Breo Ellipta Fluticasone/Vilanterol | Brand | 19 | $10,581 | |
| Arnuity Ellipta Fluticasone Furoate | Brand | 14 | $3,718 | |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | Brand | 13 | $2,693 | |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | Brand | 13 | $2,240 | |
| Wixela Inhub Fluticasone Propion/Salmeterol | Brand | 11 | $673 | |
| Albuterol Sulfate Hfa Albuterol Sulfate | Brand | 15 | $474 | |
| Fluticasone Propionate | Generic | 23 | $445 | |
| Azelastine Hcl | Generic | 20 | $427 | |
| Montelukast Sodium | Generic | 37 | $309 |
The 10 drugs with the highest cost, of 11 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,361 Part D prescribers listed as Pediatric Medicine; they describe a distribution and say nothing about conduct.
Records
376 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Allergy/Immunology in Missouri
Jay Portnoy
Pediatric Allergy/Immunology · Kansas City, MO
Gary Goodman
Pediatric Allergy/Immunology · Saint Louis, MO
Deepika Polineni
Pediatric Allergy/Immunology · Saint Louis, MO
Ray Davis
Pediatric Allergy/Immunology · Saint Louis, MO
Lisa Suffian
Pediatric Allergy/Immunology · Saint Louis, MO
Mary Jacobson
Pediatric Allergy/Immunology · Kansas City, MO
Related records
Pediatric Allergy/Immunology in Missouri
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Allergy/Immunology
Everyone recorded under this specialty, nationwide.
Doctors in Missouri
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.